Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2022-06-21–present
Board Member
Bausch Health Companies Inc. (BHC)Equibles does not estimate personal net worth.
Get an email with a short summary when Bausch Health Companies Inc. publishes a filing, an earnings call transcript or a press release.
Get BHC alertsBrett Icahn is recorded as Board Member at Bausch Health Companies Inc. (BHC) since June 21, 2022. Bausch Health Companies Inc. reported in an 8-K filed August 15, 2025 that Brett Icahn resigned as board of directors, effective August 14, 2025. The same filing states: “The resignations of Messrs. Icahn and Miller did not result from any disagreement with the Company.” Bausch Health Companies Inc. reported in an 8-K filed June 24, 2022 that Brett Icahn was appointed Director, effective June 21, 2022. Bausch Health Companies Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Bausch Health Companies Inc. includes Joseph Papa (CEO), Thomas Appio (CEO), Thomas J. Appio (CEO and Board Member) and 7 others.
“On August 14, 2025, Brett M. Icahn and Steven D. Miller resigned from the board of directors (the "Board") of the Company in connection with the termination of the Appointment and Nomination Agreement.”
“The resignations of Messrs. Icahn and Miller did not result from any disagreement with the Company.”
“The shareholders elected the following individuals to the Company’s Board of Directors, to serve until the close of the Company’s 2023 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director’s earlier resignation or removal:”
2022-06-21–present
2022-06-21–2025-08-14
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2022-06-21–present
“The resignations of Messrs. Icahn and Miller did not result from any disagreement with the Company.”
Bausch Health Companies Inc. (BHC)